Abstract: The present invention is directed to D-homoandrosta-17-yl-carbamate derivatives as selective glucocorticoid receptor ligands useful for treating a variety of autoimmune and inflammatory diseases or conditions. Pharmaceutical compositions and methods of use are also included.
Type:
Grant
Filed:
May 15, 2006
Date of Patent:
June 29, 2010
Assignee:
Merck Sharp & Dohme Corp.
Inventors:
Amjad Ali, Mark L. Greenlee, Carol A. McVean, Robert S. Meissner, Gayle E. Taylor